Calculated based on number of publications stored in Pure and citations from Scopus
20142022

Research activity per year

If you made any changes in Pure these will be visible here soon.
Filter
Article

Search results

  • 2022

    A unified citywide dashboard for allocation and scheduling dialysis for COVID-19 patients on maintenance hemodialysis

    On Behalf Of The 'project Victory' Consortium, 1 May 2022, In: Indian Journal of Nephrology. 32, 3, p. 197-205 9 p.

    Research output: Contribution to journalArticlepeer-review

    1 Scopus citations
  • CLL-120 Pirtobrutinib, A Highly Selective, Non-Covalent (Reversible) BTK Inhibitor in Previously Treated CLL/SLL: Updated Results from the Phase 1/2 BRUIN Study

    Coombs, C. C., Pagel, J. M., Shah, N. N., Lamanna, N., Munir, T., Lech-Maranda, E., Eyre, T. A., Woyach, J. A., Wierda, W. G., Cheah, C. Y., Cohen, J. B., Roeker, L. E., Patel, M. R., Fakhri, B., Barve, M. A., Tam, C. S., Lewis, D., Gerson, J. N., Alencar, A., Ujjani, C., & 17 othersFlinn, I., Sundaram, S., Ma, S., Jagadeesh, D., Rhodes, J., Taylor, J., Abdel-Wahab, O., Ghia, P., Schuster, S. J., Wang, D., Nair, B., Zhu, E., Tsai, D. E., Davids, M. S., Brown, J. R., Jurczak, W. & Mato, A. R., Oct 2022, In: Clinical Lymphoma, Myeloma and Leukemia. 22, p. S268-S269

    Research output: Contribution to journalArticlepeer-review

    2 Scopus citations
  • MCL-133 Pirtobrutinib, a Highly Selective, Non-Covalent (Reversible) BTK Inhibitor in Previously Treated Mantle Cell Lymphoma: Updated Results From the Phase 1/2 BRUIN Study

    Cohen, J. B., Shah, N. N., Alencar, A. J., Gerson, J. N., Patel, M. R., Fakhri, B., Jurczak, W., Tan, X. N., Lewis, K. L., Fenske, T., Coombs, C. C., Flinn, I. W., Lewis, D. J., Gouill, S. L., Palomba, M. L., Woyach, J. A., Pagel, J. M., Lamanna, N., Barve, M. A., Ghia, P., & 15 othersEyre, T. A., Zinzani, P. L., Ujjani, C. S., Koh, Y., Izutsu, K., Lech-Maranda, E., Tam, C. S., Sundaram, S., Yin, M., Nair, B., Tsai, D. E., Balbas, M., Mato, A. R., Cheah, C. Y. & Wang, M. L., Oct 2022, In: Clinical Lymphoma, Myeloma and Leukemia. 22, p. S394-S395

    Research output: Contribution to journalArticlepeer-review

    2 Scopus citations
  • Ofatumumab plus HyperCVAD/HD-MA induction leads to high rates of minimal residual disease negativity in patients with newly diagnosed mantle cell lymphoma: Results of a phase 2 study

    Torka, P., Akhtar, O. S., Reddy, N. M., Baysal, B. E., Kader, A., Groman, A., Nichols, J., Mavis, C., Tario, J. D., Block, A. M. W., Sait, S. N. J., Ghione, P., Sundaram, S., Przespolewski, E. R., Mohr, A., Lund, I., Kostrewa, J., McWhite, K., DeMarco, J., Johnson, M., & 6 othersDarrall, A., Thomas-Talley, R. N., Wallace, P. K., Neppalli, V., Hutson, A. & Hernandez-Ilizaliturri, F. J., 15 Apr 2022, In: Cancer. 128, 8, p. 1595-1604 10 p.

    Research output: Contribution to journalArticlepeer-review

  • 2021

    Burkitt Lymphoma International Prognostic Index

    The Burkitt Lymphoma International Prognostic Index Consortium, 1 Apr 2021, In: Journal of Clinical Oncology. 39, 10, p. 1129-1138 10 p.

    Research output: Contribution to journalArticlepeer-review

    15 Scopus citations
  • Burkitt lymphoma in the modern era: Real-world outcomes and prognostication across 30 US cancer centers

    Evens, A. M., Danilov, A., Jagadeesh, D., Sperling, A., Kim, S. H., Vaca, R., Wei, C., Rector, D., Sundaram, S., Reddy, N., Lin, Y., Farooq, U., D'Angelo, C., Bond, D. A., Berg, S., Churnetski, M. C., Godara, A., Khan, N., Choi, Y. K., Yazdy, M., & 38 othersRabinovich, E., Varma, G., Karmali, R., Mian, A., Savani, M., Burkart, M., Martin, P., Ren, A., Chauhan, A., Diefenbach, C., Straker-Edwards, A., Klein, A. K., Blum, K. A., Boughan, K. M., Smith, S. E., Haverkos, B. M., Orellana-Noia, V. M., Kenkre, V. P., Zayac, A., Ramdial, J., Maliske, S. M., Epperla, N., Venugopal, P., Feldman, T. A., Smith, S. D., Stadnik, A., David, K. A., Naik, S., Lossos, I. S., Lunning, M. A., Caimi, P., Kamdar, M., Palmisiano, N., Bachanova, V., Portell, C. A., Phillips, T., Olszewski, A. J. & Alderuccio, J. P., 21 Jan 2021, In: Blood. 137, 3, p. 374-386 13 p.

    Research output: Contribution to journalArticlepeer-review

    Open Access
    36 Scopus citations
  • COVID-19 in patients with CLL: improved survival outcomes and update on management strategies

    Roeker, L. E., Eyre, T. A., Thompson, M. C., Lamanna, N., Coltoff, A. R., Davids, M. S., Baker, P. O., Leslie, L., Rogers, K. A., Allan, J. N., Cordoba, R., Lopez-Garcia, A., Antic, D., Pagel, J. M., Martinez-Calle, N., García-Marco, J. A., Hernández-Rivas, J. Á., Miras, F., Coombs, C. C., Österborg, A., & 32 othersHansson, L., Seddon, A. N., López Jiménez, J., Wilson, M. R., El-Sharkawi, D., Wojenski, D., Ma, S., Munir, T., Valenciano, S., Seymour, E., Barr, P. M., Pu, J., Patten, P. E. M., Perini, G. F., Huntington, S. F., Parry, H., Sundaram, S., Skarbnik, A., Kamdar, M., Jacobs, R., Walter, H., Walewska, R., Broom, A., Lebowitz, S., Isaac, K. M., Portell, C. A., Ahn, I. E., Ujjani, C. S., Shadman, M., Skånland, S., Chong, E. A. & Mato, A. R., 4 Nov 2021, In: Blood. 138, 18, p. 1768-1773 6 p.

    Research output: Contribution to journalArticlepeer-review

    Open Access
    32 Scopus citations
  • HIV-associated Burkitt lymphoma: Outcomes from a US-UK collaborative analysis

    Alderuccio, J. P., Olszewski, A. J., Evens, A. M., Collins, G. P., Danilov, A. V., Bower, M., Jagadeesh, D., Zhu, C., Sperling, A., Kim, S. H., Vaca, R., Wei, C., Sundaram, S., Reddy, N., Pria, A. D., D'Angelo, C., Farooq, U., Bond, D. A., Berg, S., Churnetski, M. C., & 39 othersGodara, A., Khan, N., Choi, Y. K., Kassam, S., Yazdy, M., Rabinovich, E., Post, F. A., Varma, G., Karmali, R., Burkart, M., Martin, P., Ren, A., Chauhan, A., Diefenbach, C., Straker-Edwards, A., Klein, A., Blum, K. A., Boughan, K. M., Mian, A., Haverkos, B. M., Orellana-Noia, V. M., Kenkre, V. P., Zayac, A., Maliske, S. M., Epperla, N., Caimi, P., Smith, S. E., Kamdar, M., Venugopal, P., Feldman, T. A., Rector, D., Smith, S. D., Stadnik, A., Portell, C. A., Lin, Y., Naik, S., Montoto, S., Lossos, I. S. & Cwynarski, K., 27 Jul 2021, In: Blood advances. 5, 14, p. 2852-2862 11 p.

    Research output: Contribution to journalArticlepeer-review

    Open Access
    11 Scopus citations
  • Outcomes of Burkitt lymphoma with central nervous system involvement: Evidence from a large multicenter cohort study

    Zayac, A. S., Evens, A. M., Danilov, A., Smith, S. D., Jagadeesh, D., Leslie, L. A., Wei, C., Kim, S. H., Naik, S., Sundaram, S., Reddy, N., Farooq, U., Kenkre, V. P., Epperla, N., Blum, K. A., Khan, N., Singh, D., Alderuccio, J. P., Godara, A., Yazdy, M. S., & 37 othersDiefenbach, C., Rabinovich, E., Varma, G., Karmali, R., Shao, Y., Trabolsi, A., Burkart, M., Martin, P., Stettner, S., Chauhan, A., Choi, Y. K., Straker-Edwards, A., Klein, A., Churnetski, M. C., Boughan, K. M., Berg, S., Haverkos, B. M., Orellana-Noia, V. M., D'Angelo, C., Bond, D. A., Maliske, S. M., Vaca, R., Magarelli, G., Sperling, A., Gordon, M. J., David, K. A., Savani, M., Caimi, P., Kamdar, M., Lunning, M. A., Palmisiano, N., Venugopal, P., Portell, C. A., Bachanova, V., Phillips, T., Lossos, I. S. & Olszewski, A. J., Jul 2021, In: Haematologica. 106, 7, p. 1932-1942 11 p.

    Research output: Contribution to journalArticlepeer-review

    Open Access
    12 Scopus citations
  • Pirtobrutinib in relapsed or refractory B-cell malignancies (BRUIN): a phase 1/2 study

    Mato, A. R., Shah, N. N., Jurczak, W., Cheah, C. Y., Pagel, J. M., Woyach, J. A., Fakhri, B., Eyre, T. A., Lamanna, N., Patel, M. R., Alencar, A., Lech-Maranda, E., Wierda, W. G., Coombs, C. C., Gerson, J. N., Ghia, P., Le Gouill, S., Lewis, D. J., Sundaram, S., Cohen, J. B., & 24 othersFlinn, I. W., Tam, C. S., Barve, M. A., Kuss, B., Taylor, J., Abdel-Wahab, O., Schuster, S. J., Palomba, M. L., Lewis, K. L., Roeker, L. E., Davids, M. S., Tan, X. N., Fenske, T. S., Wallin, J., Tsai, D. E., Ku, N. C., Zhu, E., Chen, J., Yin, M., Nair, B., Ebata, K., Marella, N., Brown, J. R. & Wang, M., 6 Mar 2021, In: The Lancet. 397, 10277, p. 892-901 10 p.

    Research output: Contribution to journalArticlepeer-review

    134 Scopus citations
  • 2020

    Aggressive lymphoma subtype is a risk factor for venous thrombosis. Development of lymphoma - specific venous thrombosis prediction models

    Dharmavaram, G., Cao, S., Sundaram, S., Ayyappan, S., Boughan, K., Gallogly, M., Malek, E., Metheny, L., Tomlinson, B., Otegbeye, F., Lazarus, H. M., Cooper, B., Fu, P., de Lima, M. & Caimi, P. F., 1 Aug 2020, In: American Journal of Hematology. 95, 8, p. 918-926 9 p.

    Research output: Contribution to journalArticlepeer-review

    6 Scopus citations
  • Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 4.2020, NCCN Clinical Practice Guidelines in Oncology

    Wierda, W. G., Byrd, J. C., Abramson, J. S., Bilgrami, S. F., Bociek, G., Brander, D., Brown, J., Chanan-Khan, A. A., Chavez, J. C., Coutre, S. E., Davis, R. S., Fletcher, C. D., Hill, B., Kahl, B. S., Kamdar, M., Kaplan, L. D., Khan, N., Kipps, T. J., Lim, M. S., Ma, S., & 10 othersMalek, S., Mato, A., Mosse, C., Shadman, M., Siddiqi, T., Stephens, D., Sundaram, S., Wagner, N., Dwyer, M. & Sundar, H., 1 Feb 2020, In: Journal of the National Comprehensive Cancer Network : JNCCN. 18, 2, p. 185-217 33 p.

    Research output: Contribution to journalArticlepeer-review

    57 Scopus citations
  • Diffuse large B-Cell lymphoma associated with paraneoplastic Guillain–Barré syndrome: A diagnostic and therapeutic challenge

    Deb, B., Pandey, M. R., Torka, P. & Sundaram, S., 2020, (Accepted/In press) In: Hematology/ Oncology and Stem Cell Therapy.

    Research output: Contribution to journalArticlepeer-review

    Open Access
    2 Scopus citations
  • Outcomes of COVID-19 in patients with CLL: a multicenter international experience

    Mato, A. R., Roeker, L. E., Lamanna, N., Allan, J. N., Leslie, L., Pagel, J. M., Patel, K., Osterborg, A., Wojenski, D., Kamdar, M., Huntington, S. F., Davids, M. S., Brown, J. R., Antic, D., Jacobs, R., Ahn, I. E., Pu, J., Isaac, K. M., Barr, P. M., Ujjani, C. S., & 42 othersGeyer, M. B., Berman, E., Zelenetz, A. D., Malakhov, N., Furman, R. R., Koropsak, M., Bailey, N., Hanson, L., Perini, G. F., Ma, S., Ryan, C. E., Wiestner, A., Portell, C. A., Shadman, M., Chong, E. A., Brander, D. M., Sundaram, S., Seddon, A. N., Seymour, E., Patel, M., Martinez-Calle, N., Munir, T., Walewska, R., Broom, A., Walter, H., El-Sharkawi, D., Parry, H., Wilson, M. R., Patten, P. E. M., Hernández-Rivas, J. Á., Miras, F., Escalada, N. F., Ghione, P., Nabhan, C., Lebowitz, S., Bhavsar, E., López-Jiménez, J., Naya, D., Garcia-Marco, J. A., Skånland, S. S., Cordoba, R. & Eyre, T. A., 3 Sep 2020, In: Blood. 136, 10, p. 1134-1143 10 p.

    Research output: Contribution to journalArticlepeer-review

    175 Scopus citations
  • Outcomes of patients with limited-stage aggressive large B-cell lymphoma with high-risk cytogenetics

    Torka, P., Kothari, S. K., Sundaram, S., Li, S., Medeiros, L. J., Ayers, E. C., Landsburg, D. J., Bond, D. A., Maddocks, K. J., Giri, A., Hess, B., Pham, L. Q., Advani, R., Liu, Y., Barta, S. K., Vose, J. M., Churnetski, M. C., Cohen, J. B., Burkart, M., Karmali, R., & 12 othersZurko, J., Mehta, A., Olszewski, A. J., Lee, S., Hill, B. T., Burns, T. F., Lansigan, F., Rabinovich, E., Peace, D., Groman, A., Attwood, K. & Hernandez-Ilizaliturri, F. J., 28 Jan 2020, In: Blood advances. 4, 2, p. 253-262 10 p.

    Research output: Contribution to journalArticlepeer-review

    Open Access
    20 Scopus citations
  • Utility of bone marrow aspirate and biopsy in staging of patients with T-cell lymphoma in the PET-Era–tissue remains the issue

    Sundaram, S., Jizzini, M., Lamonica, D., Attwood, K., Gravina, M., Hernandez-Ilizaliturri, F. & Torka, P., 2020, In: Leukemia and Lymphoma. 61, 13, p. 3226-3233 8 p.

    Research output: Contribution to journalArticlepeer-review

    4 Scopus citations
  • 2014

    Eosinophilic fasciitis as a paraneoplastic syndrome, a case report and review of the literature

    Haddad, H., Sundaram, S., Magro, C. & Gergis, U., Jun 2014, In: Hematology/ Oncology and Stem Cell Therapy. 7, 2, p. 90-92 3 p.

    Research output: Contribution to journalArticlepeer-review

    Open Access
    26 Scopus citations